President and CEO Novozymes A/S, Denmark
Novo Nordisk Foundation, Denmark; Vice-Chair Novo Holding, Denmark; Vice-Chair of Villum Foundation, Denmark; Chair of Xellia, Denmark
First appointed in 2014
Current term of office 2022-2024
Steen Riisgaard was appointed at the annual General Meeting of Shareholders in May 2014.
His current term of office runs from 2022 – 2024.
Steen Riisgaard served as President and CEO of Novozymes. Currently, he serves the Novo Nordisk Foundation, Denmark, Vice-Chair of Novo Holding, Denmark, Vice-Chair of Villum Foundation, Denmark, and Chair of Xellia, Denmark.
Steen Riisgaard holds the Danish nationality and was born in 1951.